Cardiovascular Week articles from November 2004

Cardiovascular Week archives from November 2004

Endogenous angiotensin II promotes induction of vulnerable plaques.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Endogenous angiotensin II induces atherosclerotic plaque vulnerability and elicits a Th1 response in ApoE[superscript]-/- mice. According to recent research from Switzerland, "Rupture of vulnerable...

Infection caused by periodontal pathogens is associated with future stroke.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Researchers have investigated antibodies to periodontal pathogens and stroke risk. According to a recent study published in the journal Stroke, "The association between cerebrovascular events and...

Plasticity-enhancing effect of D-amphetamine is not related to its CV arousal.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- D-amphetamine boosts language learning independent of its cardiovascular and motor arousing effects. According to recent research published in the journal Neuropsychopharmacology, "D-Amphetamine...

Transcatheter PFO closure may be less successful than reported previously.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- A prospective study with transcranial Doppler was used to evaluate transcatheter closure of patent foramen ovale. According to a study from Italy, "Transcatheter closure of patent foramen ovale...

Reduced plasma glutathione levels are a risk factor for cardiovascular disease.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- A report from the Hisayama study describes the relationship between plasma glutathione levels and cardiovascular disease in a defined population. Scientists in Japan report, "Glutathione (GSH)...

Estrogen protects male rats from aneurysm.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- When it comes to abdominal aortic aneurysms - life-threatening bulges or weak areas in the main artery feeding blood to the lower half of the body - it is definitely better to be female. During...

FDA approves medical device to treat AAA.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Cook, Inc., a privately held medical-device manufacturer, announced that the U.S. Food and Drug Administration (FDA) has approved the company's next-generation solution for abdominal aortic aneurysms...

New technique to repair aneurysms safer.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Repairing a life-threatening bulge in a major stomach artery by threading a patch up from the groin appears to sharply cut the short-term risk of death and complications, compared with traditional...

Study suggests caution against using certain drugs to unclog heart arteries.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Dartmouth Medical School cardiology researchers have discovered a new mechanism for what drives the growth of muscle tissue in the lining of injured heart vessels that can eventually lead to blockage....

Pharma company's long-term study of Celebrex expected to continue.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Pfizer Inc. said that three large long-term Celebrex (celecoxib capsules) studies involving more than 6,000 patients have not shown any significant safety issues and are expected to continue to...

CytRx adds three drug candidates with acquisition of Biorex assets.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- CytRx Corp. (CYTR) has acquired all the clinical and pharmaceutical assets and related intellectual property of Hungary-based Biorex Research & Development, RT, (Biorex), a privately held biotechnology...

Study investigates cardiovascular responses to norepinephrine.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Researchers have investigated regional and temporal changes in cardiovascular responses to norepinephrine and vasopressin during continuous infusion of lipopolysaccharide in conscious rats. Reduced...

Porcine model study found propofol to be more arrhythmogenic than thiopental.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- An electrophysiological study in a porcine model including acute alcoholic intoxication has been conducted to investigate the comparative effects of thiopental and propofol on atrial vulnerability. ...

Company introduces low permeability AAA Device.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- W. L. Gore & Associates, Inc., a manufacturer of expanded polytetrafluoroethylene (ePTFE) vascular grafts and endovascular devices including the GORE EXCLUDER Bifurcated Endoprosthesis, announced...

System may aid therapies to lower incidence of acute coronary artery diseases.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- A recent report described an intravascular probe for detection of vulnerable plaque. Investigators in the United States report, "Coronary angiography defines geometry of lumen of artery. However,...

Vitamin E can increase carotid artery compliance and baroreflex gain.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- A recent report described the effect of vitamin E on carotid artery elasticity and baroreflex gain in young, healthy adults. According to published research from Hungary, "In [our] study we tested...

Abnormal homocysteine metabolism not key factor in autoimmune disorder.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Study results suggest abnormal homocysteine metabolism is not a key factor in the development of antiphospholipid syndrome. "Recent studies have identified hyperhomocysteinemia as a risk factor for...

FDA approves first U.S. implants of Philos II DR-T pacemaker.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Biotronik, Inc., announced U.S. Food and Drug Administration (FDA) approval and first implants of a second-generation Home Monitoring product: the Philos II DR-T pacemaker. The device is part of a...

Research shows gelatine stimulates synthesis of type II collagen.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Collagen hydrolysate (CH), a special type of gelatine, was shown to stimulate synthesis of type II collagen in a study presented at the annual meeting of the American Society for Bone and Mineral...

Company addresses possible reimbursement for VentrAssist LVAS.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Ventracor, Ltd., (VCR), said there was evidence the cost of its artificial heart devices used in its pending U.S. clinical trials would be fully reimbursed and there was potential for reimbursement at...

Drug for rheumatism possible boon to heart patients.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Atherosclerosis, which lies behind heart attacks, stroke and other cardiovascular problems, has a major impact on public health. So does chronic rheumatoid arthritis. These two diseases are completely...

Results presented on antibody-based treatment of atherosclerosis.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- A new report describes the research performed by a research team lead by professor Jan Nilsson at the University Hospital MAS in Malmo in collaboration with BioInvent International AB (BINV) in Lund....

Cholesteryl ester transfer protein induces long-lasting antibodies.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Subcutaneous and mucosal administration of a 26-amino acid cholesteryl ester transfer protein (CETP) epitope carried by heat shock protein 65 kDa in the absence of adjuvants induced long-lasting...

Alcohol consumption may be associated with irregular heartbeat in men.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Alcohol consumption may slightly increase the risk for developing a certain type of irregular heart beat, known as atrial fibrillation, or atrial flutter, according to new research. Evidence for a...

Anisotropic, decremental conduction occurs during onset of atrial fibrillation.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- A recent report described conduction characteristics at the crista terminalis during onset of pulmonary vein atrial fibrillation. According to a study from Australia, "Focal atrial fibrillation...

Asymptomatic atrial fibrillation after catheter ablation infrequent.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Researchers have investigated the prevalence of asymptomatic recurrences of atrial fibrillation after successful radiofrequency catheter ablation. Scientists in the United States report, "The...

Biphasic cardioversion allows comparable success rates with lower energies.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Researchers have investigated the impact of biphasic electrical cardioversion of atrial fibrillation on early recurrent atrial fibrillation and shock efficacy. According to recent research published...

Wave characteristics were repeatable from ECG to ECG for stable patients.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Researchers have investigated atrial fibrillatory wave characteristics on surface electrograms and ECG to ECG repeatability over twenty-four hours in clinically stable patients. "Fibrillatory waves...

Beta-radiation can create linear lesions that are contiguous and nonthrombogenic.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- A recent report described the use of beta-radiation for the creation of linear lesions in the canine atrium. Creating linear lesions is important for the treatment of arrhythmias such as atrial...

Atrial hemodynamic burden is a determinant of sustained ANP response.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- A recent study investigated atrial natriuretic peptides during experimental atrial tachycardia and the role of developing tachycardiomyopathy. According to a study from Netherlands, "Atrial...

Colic infants do not have abnormal autonomic reactivity to stimuli while asleep.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- A recent report described heart rate variability in response to the sleep-related movements in infants with and without colic. According to a study from Finland, "The activity of the autonomic...

Enterococcus faecalis fsr two-component system controls biofilm development.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- The Enterococcus faecalis fsr two-component system was seen to control biofilm development through production of gelatinase. According to recent research published in the Journal of Bacteriology,...

Swedish company presents mass screening tests at investment conference.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Swedish blood diagnostics company LifeAssays Inc. presented its mass screening and point-of-care tests on Oct. 21 at the Windhover Information and Medtech Insight's "Investment In Innovation" Event, at...

Obesity surgery can cure diabetes, high blood pressure and other ills.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Patients who undergo obesity, or bariatric, surgery get far more than cosmetic benefits, many also shed fat-related ailments including diabetes, high blood pressure and high cholesterol, researchers...

Gen-Probe signs licensing agreements.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Gen-Probe (GPRO) has signed nonexclusive licensing agreements with bioMerieux and its affiliates that provide bioMerieux options to access Gen-Probe's ribosomal RNA technologies for certain uses, and...

For optimal health, cut even more body fat, says report.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Thirty-five percent of Americans have a normal body weight, and until recently doctors thought that normal was good enough. But a recent Harvard study discussed in the October 2004 issue of the...

Study links low HDL levels with increased risk of postmenopausal breast cancer.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- The 2004 update from the American Heart Association's (AHA) Heart Disease and Stroke Statistics, coupled with a recently published study, documents that more than 50 million American women have...

Epicardial cooling could be an in vivo experimental model of Brugada syndrome.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- A recent report described a canine model of Brugada syndrome using regional epicardial cooling of the right ventricular outflow tract. According to recent research published in the Journal of...

Cardiology instrument designer and manufacturer added to Russell Indices.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Stereotaxis, Inc. (STXS) announced that it has been added to the Russell 3000 and Russell 2000 Indices, as of October 1, 2004. "As a company that has recently completed an initial public offering,...

Medical monitoring service changes stock symbol.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Medeorex, Inc., (MRXI) announced that it has completed a change in its stock trading symbol on the NASD Over-The-Counter Bulletin Board to "MRXI" from "CXTX." The company previously changed its...

Toddler with uncommon condition showing improvement.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- When Marques Jehium Turks was born in the Arkansas Delta town of Dumas, his doctor knew the baby needed specialized care. He was immediately transferred to Arkansas Children's Hospital in Little...

Ephedrine linked to sudden cardiac death.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Each year 80,000-100,000 Americans die suddenly from heart attacks without ever having had any symptoms of heart disease. In some cases, the victims of these unheralded sudden cardiac deaths had been...

Biventricular ICDs offer survival benefit compared to biventricular pacing alone.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Biventricular implantable cardioverter defibrillators improve survival compared with biventricular pacing alone in patients with severe left ventricular dysfunction. According to a study from the...

Long-term monitoring of SvO[subscript]2 by implanted devices may be feasible.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- A recent report described the results of 6 years follow-up of an implanted SvO[subscript]2 sensor in the right ventricle. According to a study from the United States, "mixed venous oxygen...

Thin filament is key modulator of contractile performance in failing human heart.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Recent research investigated the role of thin filament-based modulation of contractile performance in human heart failure. "The contribution of the sarcomere's thin filament to the contractile...

Responses may influence cardiac performance during eccentric cardiac hypertrophy.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Recent research investigated the modulation of atrial contraction by PKA and PKC during the compensated phase of eccentric cardiac hypertrophy. According to recent research from the United States,...

FDA approves marketing a newly developed cardiac monitor.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Criticare Systems, Inc., (CMD) (CSI) has received notification from the FDA (U.S. Food and Drug Administration) that it has been granted approval to market a cardiac monitor with magnetic resonance...

Real-time PCR is an efficient method to detect PVB19 infection in heart tissue.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Researchers have reported on their analysis of myocardial tissue from explanted hearts of heart transplant recipients and multi-organ donors for the presence of parvovirus B19 DNA. According to a...

After initial damage, protective mechanisms within the heart were initiated.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Researchers have reported the results of a short-term time-course study of bis(2-chloroethoxy) methane-induced mitochondrial and myofibrillar damage. Scientists writing in the journal Toxicological...

Columbus Regional Hospital receives Chest Pain Center accreditation.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- The Society of Chest Pain Centers has granted the designation of Accredited Chest Pain Center to Columbus (Indiana) Regional Hospital, making it the fourth accredited Chest Pain Center in Indiana and...

Correlation found between exhaled NO changes with exercise and peak V[subscript]O[superscript]2.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Exercise-induced changes in exhaled nitric oxide in heart failure were the focus of a recent report. In heart failure abnormalities of pulmonary function are frequently observed as shown by...

Electroporation of hepatocyte growth factor DNA treats cardiomyopathy.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Electroporation of hepatocyte growth factor DNA treats cardiomyopathy. "Hepatocyte growth factor (HGF) is a potent angiogenic and antifibrotic factor. Cardioprotective effects of HGF for idiopathic...

Endogenous Ang II may modulate inward calcium current in the failing heart.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Intracellular and extracellular angiotensin II enhance the L-type calcium current in the failing heart. Scientists in the United States report, "The influence of intracellular and extracellular...

European pharmaceutical awards $1.3M for electrocardiographic services.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- eResearchTechnology, Inc., (eRT) (ERES), provider of centralized electrocardiographic (ECG) collection and interpretation services, has been awarded a thorough phase I ECG (electrocardiogram) study...

Heart rate, load effects on viscoelastic properties studied in animal model.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Heart rate and pre- and afterload effects on viscoelastic properties were studied in a swine myocardium model. Researchers in the United States performed "[e]xperiments... to test the hypothesis...

LV systolic dysfunction was a strong predictor of mortality and morbidity.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- A recent report described the prognosis of impaired left ventricular systolic function and heart failure in a middle-aged and elderly population in an urban population segment of Copenhagen. ...

New catheter available for crossing chronic total occlusions.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Catheter technology company LuMend Inc. has launched a new re-entry catheter for peripheral crossing technology. According to LuMend, its new system, called the Outback Re-Entry Catheter, is the...

New treatment may help prevent blood clots.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Canadian cardiovascular research company Medicure (MCU) announced that preliminary results have shown significant potential for its newest drug, MC-45308, in preventing blood clots. The results...

P-wave dispersion was higher in patients with dilated cardiomyopathy.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- A recent report described P-wave duration and P-wave dispersion in patients with dilated cardiomyopathy. Investigators in Turkey wrote, "P-wave dispersion (PWD) has been reported to be associated...

Flemish T.V. watchers overestimate succcess of CPR.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- A recent study of incidences of cardiopulmonary resuscitation on Flemish television challenges the "television effects" hypothesis. According to that study, "People who watch a lot of medical...

Biopharmaceutical company announces CARE 2 study.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Nabi Biopharmaceuticals (NASDAQ:NABI) announced that it is replacing the PhosLo PRECISE Study with the CARE 2 study that will compare efficacy and arterial calcification in patients treated with PhosLo...

Biosciences company enters collaboration to study genetics of heart disease.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- ParAllele BioScience announced that it has entered into collaboration with Novartis Pharma AG to discover genetic variations associated with coronary artery disease. Coronary artery disease affects...

Data on Thelin presented at American College of Rheumatology Meeting.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Encysive Pharmaceuticals (NASDAQ:ENCY) announced that new clinical data on Thelin (sitaxsentan) was presented at the American College of Rheumatology (ACR) Annual Scientific Meeting in San Antonio,...

Decline in subarachnoid hemorrhage mortality is different in men than in women.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Researchers have reported declining mortality from subarachnoid hemorrhage in Sweden. Scientists writing in the journal Stroke report, "Northern Sweden has one of the highest incidence rates of...

Prospective cohort study of the MONICA population published in Circulation.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- A prospective cohort study of the MONICA population, a landmark 14-year population study, was published in today's issue of Circulation, the journal of the American Heart Association. Data from the...

Evidence suggests that respiratory chain enzyme complexes are associated.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Kinetic evidence using flux control analysis reveals that the mitochondrial respiratory chain is partially organized in a supercomplex assembly. According to a study from Italy, "The model of the...

Transesophageal echocardiography is used to diagnose aortic and cardiac injuries.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Bedside echocardiography in chest trauma was the focus of a recent report. Scientists in the United States report, "Bedside ultrasound is an evolving standard of care in the evaluation of patients...

Cholesterol guidelines become a morality play about conflict of interest.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- They led influential medical groups, starred at prestigious meetings, published in top journals and were undisputed giants in their field. But when nine famous doctors advised the government...

New drug designed to reduce cholesterol levels launched.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Lek, a new Sandoz company, launched atorvastatin, a drug designed to reduce cholesterol levels, on the Czech market. Atorvastatin was registered in the Czech Republic on the basis of in-house...

Questionnaire is sensible and valid for estimation of daily energy expenditure.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Researchers have evaluated a questionnaire-based assessment of daily physical activity in heart failure. According to recent research published in the European Journal of Heart Failure, "Type and...

Sinus node remodeling is characterized by reduced functional sinus node reserve.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Recent research has provided insights about the remodeling of sinus node function in patients with congestive heart failure, including a reduction in sinus node reserve. According to a study from...

Fasudil attenuates post-CABG coronary artery spasm.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Fasudil treatment can attenuate coronary artery spasm after coronary artery bypass grafting (CABG). Scientists in Japan "recently demonstrated that fasudil, a Rho-kinase inhibitor, is effective in...

Pericardial/serum myoglobin ratio may mark perioperative myocardial infarction.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- The pericardial/serum myoglobin (MG) ratio may aid diagnosis of perioperative myocardial infarction (MI) in patients undergoing coronary artery bypass grafting (CABG). "Pericardial fluid reflects...

3-D fusion imaging is useful in decisions about coronary artery disease.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- A recent study evaluated 3-D integration of myocardial scintigraphic data of patients with ischemic cardiomyopathy. Researchers in Germany conducted a study "to determine the prevalence of viable...

Ascending aortic BP waveform may be related to CAD risk in women, but not men.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Ascending aortic blood pressure waveform may be related to coronary artery disease risk in women, but not men, report cardiologists in Poland. "Recent studies have demonstrated that fractional pulse...

Pharma company releases phase 1 results for coronary atherosclerosis treatment.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Pharmacyclics, Inc. (NASDAQ:PCYC) announced the presentation of phase 1 trial results describing the use of Antrin (motexafin lutetium) phototherapy for the treatment of coronary atherosclerosis. ...

Company announces final research report on cystic fibrosis treatment.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Biotech company Medical Discoveries (MLSC) announced receipt of the last in a series of research reports required by the U.S. Food & Drug Administration (FDA) for the company's submission of an...

Cardiac troponin I concentration increases in diabetic ketoacidosis.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Cardiac troponin I concentration increases in diabetic ketoacidosis. Researchers from Turkey conducted a study "to examine the hypothesis that diabetic ketoacidosis may be associated with some...

Therapies for ventricular hypertrophy compared in diabetic patients.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Scientists have compared the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2...

Treating albuminuria may prevent heart disease in diabetic patients.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Albuminuria is a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Albuminuria is an established risk marker for both cardiovascular and renal outcomes....

Life sciences company announces Nanobacteria blood test manufacturing agreement.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Nanobac Life Sciences, Inc., (OTCPK: NNBP) announced the signing of a manufacturing agreement with Medicorp, Inc., for the production of two blood tests for the detection of Nanobacteria. Nanobac...

Dialysate must be purified to prevent cardiovascular events in dialysis patients.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- A recent report described lowering of oxidative stress in hemoodialysis patients by dialysate cleaning. According to researchers from Japan, "The objective of [our] study was to investigate changes...

Program improved management of patients hospitalized for heart failure.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- A recent report described a multicenter randomized trial of a comprehensive hospital discharge and outpatient heart failure management program. According to the report from Spain, "Disease...

Sense oligonucleotides targeting VEGF may help patients with ischemic tissues.
November 1, 2004... 2004 NOV 1 - (NewsRx.com & NewsRx.net) -- Sense oligonucleotides targeting VEGF may help patients with ischemic tissues. According to a study from Australia, "the regulation of vascular endothelial growth factor (VEGF), a potent stimulator...